Volver a Agenda
Patient Engagement in Pharmacovigilance
Session Chair(s)
Deborah Collyar
President, Patient Advocates In Research (PAIR), United States
This session will present current research and emerging best practices in the field of patient risk communication, including methods for collecting patient input in the design of these communication materials.
Learning Objective : Identify key elements that are needed to make patient educational materials understandable and actionable for patients in their decision-making process regarding treatment; Examine the value of patient-generated real-world safety data, public hearings, and patient input into the development of risk communication tools.
Speaker(s)
Emily Freeman, PHD, MSC
Senior Director, Patient Engagementg, Global Medical Strategyand Operations, Gilead, Inc., United States
Patient Engagement and Pharmacovigilance: Risk Interventions and Strategic Communications (RISC)
Shelley Gandhi, MS
Partner & PV trainer, Eliquent Life Sciences, United Kingdom
How Will EU Public Hearings Help with Patient and Public Engagement and How Should the Industry Prepare?
David Blaser, PHARMD
Director, Health Informatics, PatientsLikeMe, United States
Can Patient-Generated Real-World Data Illuminate Real World Evidence of Safety Concerns Sooner Than Traditional Sources?
Meredith Yearsley Smith, MPA, FISPE
Fellow and faculty member, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States
How Well Are We Doing Conveying Drug Safety Information to Patients? An Analysis of the Quality of REMS Educational Materials
¿Tiene una cuenta?